Skip to main content
TARS logo
TARS
(NASDAQ)
Tarsus Pharmaceuticals, Inc.
$70.12-- (--)
Loading... - Market loading

Tarsus Pharmaceuticals (TARS) Stock Price & Financial Analysis

Tarsus Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$69.01 - $71.37
52-Week High$85.25
52-Week Low$38.51
Open$69.06
Volume370.83K
Average Volume (3M)370.83K
Market Cap2.93B
Shares Outstanding41.78M
Price to Sales (P/S)6.50
Price to Book (P/B)8.54
EV/EBITDA-52.62
Revenue (TTM)451.36M
Net Income (TTM)-66.42M
Free Cash Flow (TTM)-22.31M
EPS (TTM)$-1.55
Profit Margin-14.72%
Operating Margin-15.72%
Return on Equity (ROE)-19.34%
Debt to Equity0.27
50-Day MA$68.33
200-Day MA$63.34
52-Week Change43.54%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Tarsus Pharmaceuticals

What is the current stock price for TARS?

As of the latest trading session, TARS stock trades at $70.12. The 52-week range is $38.51–$85.25, with a day range of $69.01–$71.37.

What is the P/E ratio for TARS?

The P/E ratio (Price-to-Earnings) for TARS is shown in the Key Statistics section. This valuation metric helps compare Tarsus Pharmaceuticals, Inc. to industry peers.

Does TARS pay dividends?

Tarsus Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TARS?

Based on 6 analysts, the consensus for TARS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TARS?

Tarsus Pharmaceuticals's market capitalization is $2.93B, classifying it as a mid-cap company. Tarsus Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.